Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Amato

Showing results (171-180 of 237) with videos related to

Pageof 24
Sort By:
Cancer|September 7, 2002
Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer CenterMingxin Che, Pheroze Tamboli, Jae Y Ro, et al.
Journal of the National Cancer Institute|April 18, 1990
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorC J Logothetis, F H Dexeus, A Sella, et al.
Biomolecules|August 26, 2023
Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?Mepur H Ravindranath, Narendranath M Ravindranath, Senthamil R Selvan, et al.
Annals of Surgical Oncology|December 2, 2011
Changes in age, stage distribution, and survival of patients with esophageal adenocarcinoma over three decades in the United StatesPutao Cen, Farzaneh Banki, Lee Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2004
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumorsKarim Fizazi, Stéphane Culine, Andrew Kramar, et al.
BMC Infectious Diseases|December 12, 2019
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic AreaMichelle J Cole, Chantal Quinten, Susanne Jacobsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumorsC J Logothetis, F H Dexeus, L Finn, et al.
Antibodies (Basel, Switzerland)|September 22, 2022
Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune HomeostasisMepur H Ravindranath, Fatiha El Hilali, Carly J Amato-Menker, et al.
Cancer Biotherapy|January 1, 1994
Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancerA Sella, R G Kilbourn, I Gray, et al.
The Journal of Urology|January 1, 1993
Surgery following response to interferon-alpha-based therapy for residual renal cell carcinomaA Sella, D A Swanson, J Y Ro, et al.
Pageof 24

Showing results (171-180 of 237) with videos related to

Sort By:
Pageof 24
Cancer|September 7, 2002
Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer CenterMingxin Che, Pheroze Tamboli, Jae Y Ro, et al.
Journal of the National Cancer Institute|April 18, 1990
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorC J Logothetis, F H Dexeus, A Sella, et al.
Biomolecules|August 26, 2023
Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?Mepur H Ravindranath, Narendranath M Ravindranath, Senthamil R Selvan, et al.
Annals of Surgical Oncology|December 2, 2011
Changes in age, stage distribution, and survival of patients with esophageal adenocarcinoma over three decades in the United StatesPutao Cen, Farzaneh Banki, Lee Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2004
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumorsKarim Fizazi, Stéphane Culine, Andrew Kramar, et al.
BMC Infectious Diseases|December 12, 2019
The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic AreaMichelle J Cole, Chantal Quinten, Susanne Jacobsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumorsC J Logothetis, F H Dexeus, L Finn, et al.
Antibodies (Basel, Switzerland)|September 22, 2022
Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune HomeostasisMepur H Ravindranath, Fatiha El Hilali, Carly J Amato-Menker, et al.
Cancer Biotherapy|January 1, 1994
Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancerA Sella, R G Kilbourn, I Gray, et al.
The Journal of Urology|January 1, 1993
Surgery following response to interferon-alpha-based therapy for residual renal cell carcinomaA Sella, D A Swanson, J Y Ro, et al.
Pageof 24